Data / Form D filings / Cyclarity Therapeutics, Inc.
Cyclarity Therapeutics, Inc.: Form D filings
Cyclarity Therapeutics, Inc., a pharmaceuticals company in Novato, CA, filed 3 Form D notices with the SEC between 2019 and 2024. The latest, on December 30, 2024, reports $10.3 million sold of a $12.8 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8001 Redwood Blvd, Novato, CA, 94945
- Phone
- (650) 906-5631
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1794705
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 30, 2024 | New notice | $12,800,267 | $10,288,140 | $2,512,127 | 19 | Dec 16, 2024 | sec.gov |
| Sep 7, 2021 | New notice | $9,999,994 | $3,519,169 | $6,480,825 | 10 | Aug 24, 2021 | sec.gov |
| Nov 25, 2019 | New notice | $3,975,000 | $1,450,001 | $2,524,999 | 9 | Nov 12, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Matthew O'Connor | Executive Officer, Director | |
| Michael Kope | Executive Officer, Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Dec 30, 2024 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Cyclarity Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.